Lincoln Capital LLC Abb Vie Inc. Transaction History

Lincoln Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 16, 2019	SELL	$77.14 - $90.79 $170,787 - $201,009	-2,214 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$77.85 - $96.01 $778 - $960	10 Added 0.45%	2,214 $204,000
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $195,957 - $217,843	2,204 New	2,204 $208,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Lincoln Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Lincoln Capital LLC with notifications on news.